Moberg Pharma AB (OMX: MOB) and Allderma today announce that the launch of Terclara® (MOB-015) is ongoing in Norway. The launch marks an important step in both companies' commercial strategy and ...
Table 5 summarizes results of this review. Topical use of terbinafine and miconazole were associated with 70% of the cellulitis results. Most tinea pedis clinical trials identify the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results